Total Payments
$20,880
2024 Payments
$3,255
Companies
72
Transactions
1,048
Medicare Patients
904
Medicare Billing
$128,990
Payment Breakdown by Category
Food & Beverage$20,545 (98.4%)
Education$249.10 (1.2%)
Other$85.63 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,545 | 1,031 | 98.4% |
| Education | $249.10 | 13 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85.63 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,667 | 134 | $0 (2024) |
| EMD Serono, Inc. | $1,576 | 70 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,484 | 60 | $0 (2022) |
| Biogen, Inc. | $1,343 | 56 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,229 | 88 | $0 (2024) |
| UCB, Inc. | $1,109 | 52 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $676.70 | 39 | $0 (2024) |
| Eisai Inc. | $676.20 | 22 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $614.09 | 23 | $0 (2024) |
| Kyowa Kirin, Inc. | $565.72 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,255 | 163 | ABBVIE INC. ($523.84) |
| 2023 | $3,314 | 183 | ABBVIE INC. ($530.73) |
| 2022 | $3,199 | 172 | ABBVIE INC. ($434.86) |
| 2021 | $2,322 | 124 | Biogen, Inc. ($243.36) |
| 2020 | $1,353 | 75 | Sunovion Pharmaceuticals Inc. ($131.45) |
| 2019 | $2,908 | 126 | EMD Serono, Inc. ($413.16) |
| 2018 | $2,705 | 134 | Sunovion Pharmaceuticals Inc. ($231.64) |
| 2017 | $1,823 | 71 | Sunovion Pharmaceuticals Inc. ($595.88) |
All Payment Transactions
1,048 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Sarepta Therapeutics, Inc. | Elevidys (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Genetic Disease | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Education | In-kind items and services | $10.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Neurology | ||||||
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Neurology | ||||||
| 11/27/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: Musculoskeletal | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $31.24 | General |
| 11/07/2024 | Amgen Inc. | UPLIZNA (Biological) | Education | In-kind items and services | $10.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $0.48 | General |
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Neurology | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Neurology | ||||||
| 11/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/23/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 194 | 316 | $65,445 | $28,142 |
| 2022 | 7 | 191 | 331 | $68,065 | $31,179 |
| 2021 | 7 | 246 | 384 | $79,140 | $36,835 |
| 2020 | 8 | 273 | 376 | $85,460 | $32,835 |
Total Patients
904
Total Services
1,407
Medicare Billing
$128,990
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 197 | $24,625 | $11,422 | 46.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 23 | 23 | $14,620 | $6,934 | 47.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 23 | 40 | $8,000 | $3,273 | 40.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 15 | 16 | $7,200 | $2,816 | 39.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $6,500 | $2,036 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,500 | $1,661 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 209 | $26,125 | $12,543 | 48.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 12 | 12 | $8,400 | $4,623 | 55.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 24 | 44 | $8,800 | $3,772 | 42.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 12 | 12 | $7,800 | $3,759 | 48.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 20 | 20 | $9,000 | $3,409 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $4,940 | $1,577 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 15 | $3,000 | $1,497 | 49.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 200 | $25,000 | $12,780 | 51.1% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 14 | 14 | $9,800 | $5,420 | 55.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 31 | 61 | $12,200 | $5,354 | 43.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 28 | 28 | $12,600 | $5,319 | 42.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 38 | $7,600 | $3,622 | 47.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $5,700 | $2,525 | 44.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 24 | 24 | $6,240 | $1,815 | 29.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 107 | 182 | $22,750 | $8,263 | 36.3% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2020 | 16 | 16 | $10,400 | $5,007 | 48.1% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2020 | 14 | 14 | $9,800 | $4,931 | 50.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 31 | 54 | $10,800 | $4,475 | 41.4% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 20 | 21 | $9,450 | $3,250 | 34.4% |
About Dr. Sameh Labib, MD
Dr. Sameh Labib, MD is a Neurology healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982771705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameh Labib, MD has received a total of $20,880 in payments from pharmaceutical and medical device companies, with $3,255 received in 2024. These payments were reported across 1,048 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($20,545).
As a Medicare-enrolled provider, Labib has provided services to 904 Medicare beneficiaries, totaling 1,407 services with total Medicare billing of $128,990. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Riverside, CA
- Active Since 11/29/2006
- Last Updated 12/14/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982771705
Products in Payments
- APTIOM (Drug) $1,748
- TYSABRI (Biological) $934.46
- BOTOX (Biological) $807.90
- Briviact (Drug) $708.34
- NUPLAZID (Drug) $676.70
- KESIMPTA (Drug) $663.11
- Xeomin (Biological) $587.25
- QULIPTA (Drug) $531.05
- UBRELVY (Drug) $499.13
- VALTOCO (Drug) $486.49
- AUBAGIO (Drug) $464.19
- ONPATTRO (Drug) $378.38
- Rebif (Biological) $356.84
- INGREZZA (Drug) $354.43
- Leqembi (Drug) $333.87
- XEOMIN (Biological) $318.96
- Nourianz (Drug) $311.08
- Fintepla (Drug) $309.29
- INBRIJA (Drug) $303.57
- Fycompa (Drug) $297.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Riverside
Dr. Elizabeth Morrison-Banks, Md, MD
Neurology — Payments: $143,617
Neurology $143,617
Dr. Maziar Farsani
Neurology — Payments: $7,808
Neurology $7,808
Dr. David Song, M.d./Ph.d, M.D./PH.D
Neurology — Payments: $4,285
Neurology $4,285
Shadi Milani-Nejad, D.o, D.O
Neurology — Payments: $2,831
Neurology $2,831
Dr. Mark Girgis, D.o, D.O
Neurology — Payments: $2,801
Neurology $2,801
Dr. Dhrupad Joshi, D.o, D.O
Neurology — Payments: $2,512
Neurology $2,512